Description
RADIOPHARMACEUTICALS - MODIFICATION TO DEOBLIGATE FOR CLOSEOUT.
Base award description: RADIOPHARMACEUTICALS
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-03-14+$363,610= $363,610
- Mod P000012025-07-08+$241= $363,851
- Mod P000022025-07-14+$7,616= $371,467
- Mod P000032026-03-02+$2,854= $374,321
- Mod P000042026-05-12-$193,994= $180,327
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-03-14 | +$363,610 | $363,610 | RADIOPHARMACEUTICALS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-07-08 | +$241 | $363,851 | RADIOPHARMACEUTICALS - RATIFICATION OF UAC |
| Mod P00002· FUNDING ONLY ACTION | 2025-07-14 | +$7,616 | $371,467 | RADIOPHARMACEUTICALS - RATIFICATION OF UAC |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-03-02 | +$2,854 | $374,321 | RADIOPHARMACEUTICALS - MODIFICATION TO INCREASE CLINS |
| Mod P00004· FUNDING ONLY ACTION | 2026-05-12 | −$193,994 | $180,327 | RADIOPHARMACEUTICALS - MODIFICATION TO DEOBLIGATE FOR CLOSEOUT. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RQAKL78AXMT5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226P0481 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $3,356,110 | FY2026 |
| 36C24426P0225 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $148,383 | FY2026 |
| 36C24226D0037 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24226N0381 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $959,170 | FY2026 |
| 36C24225N0376 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $51,681 | FY2025 |
| 36C24225N0389 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $174,072 | FY2025 |
Other recipients under 6505 from 244-NETWORK CONTRACT OFFICE 4 (36C244) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24426D0097 | CARDINAL HEALTH 414, LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $0 | FY2026 |
| 36C24426N0938 | CARDINAL HEALTH 414, LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $650,641 | FY2026 |
| 36C24426N0948 | ERA HEALTH LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $29,590 | FY2026 |
| 36C24426P0339 | NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA, INC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $126,204 | FY2026 |
| 36C24426N0663 | LUMINEX CORP | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $121,316 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24425N0451_3600_36C24421D0058_3600 · retrieved 2026-09-26.